safety concerns in clinical trials

After a two-year review, the FDA approves reopening a clinical trial of the experimental compound arimoclomol.

posted on December 8, 2009 - 5:45pm
A clinical trial of an experimental drug for ALS -- halted almost two years ago due to safety concerns –- has been given the green light to continue with a revised protocol, says CytRx Corp. of Los Angeles, the drug’s manufacturer. The U.S. Food and Drug Administration placed a hold on the phase 2b trial of arimoclomol in January 2008, saying it wanted to see more toxicity data from previously...

New content is being added every day. Please check back again.